Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hudi enteric-coated capsules versus mesalazine versus combination therapy for active ulcerative colitis
ChiCTR1800016668Phase 4Completed
- Sponsor
- Jiangsu Provincial Hospital of Traditional Chinese Medicine
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Hudi enteric-coated capsule and Salcrozine in autoimmune colitis (3 arms), sponsored by Jiangsu Provincial Hospital of Traditional Chinese Medicine. Primary endpoints: Clinical efficiency rate and Clinical remission rate. Started Jul 2014; status: completed.
02
Drugs
Hudi enteric-coated capsuleSalcrozine
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on ChiCTR1800016668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800016668.